# Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis

> **NCT00282425** · PHASE1 · TERMINATED · sponsor: **Richard Burt, MD** · enrollment: 8 (actual)

## Conditions studied

- Scleroderma

## Interventions

- **BIOLOGICAL:** Hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00282425
- **Lead sponsor:** Richard Burt, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** No subject enrolled since 2009
- **Last updated:** 2012-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282425, "Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00282425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*